| Net Cash Provided by (Used in) Operating Activities |
337M |
USD |
+83.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
503M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-1.06B |
USD |
-571% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-217M |
USD |
-8993% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
23.5M |
USD |
-86.8% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
95.6M |
USD |
+90.9% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
45.1M |
USD |
+2.3% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
100K |
USD |
|
Q1 2023 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
-8.2M |
USD |
-66.5% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
133M |
USD |
+310% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
1K |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
4.52B |
USD |
+59.3% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
1K |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
1.19B |
USD |
+44.2% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
173M |
USD |
+559% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
199M |
USD |
+26.3% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
159M |
USD |
+46.4% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |